Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

Related Articles by Review for PubMed (Select 19415771)

1.

Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine.

Knoepfler PS.

Stem Cells. 2009 May;27(5):1050-6. doi: 10.1002/stem.37. Review.

2.

The tumorigenicity of human embryonic stem cells.

Blum B, Benvenisty N.

Adv Cancer Res. 2008;100:133-58. doi: 10.1016/S0065-230X(08)00005-5. Review.

PMID:
18620095
3.

The tumorigenicity of diploid and aneuploid human pluripotent stem cells.

Blum B, Benvenisty N.

Cell Cycle. 2009 Dec;8(23):3822-30. Epub 2009 Dec 14. Review.

4.

Sources of stem cells for regenerative medicine.

Hipp J, Atala A.

Stem Cell Rev. 2008 Spring;4(1):3-11. doi: 10.1007/s12015-008-9010-8. Review.

PMID:
18286392
5.

Therapeutic potential of embryonic stem cells.

Lerou PH, Daley GQ.

Blood Rev. 2005 Nov;19(6):321-31. Review.

PMID:
16275420
6.

Pluripotent stem cells.

Verfaillie C.

Transfus Clin Biol. 2009 May;16(2):65-9. doi: 10.1016/j.tracli.2009.04.006. Epub 2009 May 12. Review.

PMID:
19442552
7.

The tumorigenicity of human embryonic and induced pluripotent stem cells.

Ben-David U, Benvenisty N.

Nat Rev Cancer. 2011 Apr;11(4):268-77. doi: 10.1038/nrc3034. Epub 2011 Mar 10. Review.

PMID:
21390058
8.

Is teratoma formation in stem cell research a characterization tool or a window to developmental biology?

Aleckovic M, Simón C.

Reprod Biomed Online. 2008 Aug;17(2):270-80. Review.

PMID:
18682004
9.

Turning straw into gold: directing cell fate for regenerative medicine.

Cohen DE, Melton D.

Nat Rev Genet. 2011 Apr;12(4):243-52. doi: 10.1038/nrg2938. Epub 2011 Mar 9. Review.

PMID:
21386864
10.

Induced pluripotent stem cells: current progress and potential for regenerative medicine.

Amabile G, Meissner A.

Trends Mol Med. 2009 Feb;15(2):59-68. doi: 10.1016/j.molmed.2008.12.003. Epub 2009 Jan 21. Review.

PMID:
19162546
11.

Cardiomyocytes from human pluripotent stem cells in regenerative medicine and drug discovery.

Braam SR, Passier R, Mummery CL.

Trends Pharmacol Sci. 2009 Oct;30(10):536-45. doi: 10.1016/j.tips.2009.07.001. Epub 2009 Sep 15. Review.

PMID:
19762090
12.

New and renewed perspectives on embryonic stem cell pluripotency.

Hoffman JA, Merrill BJ.

Front Biosci. 2007 May 1;12:3321-32. Review.

PMID:
17485302
13.

Are induced pluripotent stem cells the future of cell-based regenerative therapies for spinal cord injury?

Salewski RP, Eftekharpour E, Fehlings MG.

J Cell Physiol. 2010 Mar;222(3):515-21. doi: 10.1002/jcp.21995. Review.

PMID:
20020443
14.

Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming.

Li W, Ding S.

Trends Pharmacol Sci. 2010 Jan;31(1):36-45. doi: 10.1016/j.tips.2009.10.002. Epub 2009 Nov 4. Review.

PMID:
19896224
15.

Exploiting pluripotency for therapeutic gain.

Deng W.

Panminerva Med. 2010 Jun;52(2):167-73. Review.

PMID:
20517198
16.

Embryonic stem cells and prospects for their use in regenerative medicine approaches to motor neurone disease.

Christou YA, Moore HD, Shaw PJ, Monk PN.

Neuropathol Appl Neurobiol. 2007 Oct;33(5):485-98. Review.

PMID:
17854436
17.

The promise of stem cell research in pigs and other ungulate species.

Telugu BP, Ezashi T, Roberts RM.

Stem Cell Rev. 2010 Mar;6(1):31-41. doi: 10.1007/s12015-009-9101-1. Review.

PMID:
19949895
18.

Induced pluripotent stem (iPS) cells as in vitro models of human neurogenetic disorders.

Chamberlain SJ, Li XJ, Lalande M.

Neurogenetics. 2008 Oct;9(4):227-35. doi: 10.1007/s10048-008-0147-z. Epub 2008 Sep 13. Review.

PMID:
18791750
19.

Stretching the limits: stem cells in regeneration science.

Stocum DL, Zupanc GK.

Dev Dyn. 2008 Dec;237(12):3648-71. doi: 10.1002/dvdy.21774. Review.

20.

[Human embryonic stem cells: clinical potential and current challenges].

Oliveri RS, Andersen CY.

Ugeskr Laeger. 2008 May 19;170(21):1815-20. Review. Danish.

PMID:
18492447
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk